PlainRecalls
FDA Drug Critical Class I Terminated

Taztia XT (Diltiazem HCl) Capsules, 120 mg, Rx, Packaged and labeled as Thiamine. Re-Packaged By: Shamrock Medical Solutions, Lewis Center, Ohio, Mfg: Watson Laboratories, Corona, CA NDC 62037-0696-90

Reported: July 30, 2014 Initiated: September 27, 2011 #D-1446-2014

Product Description

Taztia XT (Diltiazem HCl) Capsules, 120 mg, Rx, Packaged and labeled as Thiamine. Re-Packaged By: Shamrock Medical Solutions, Lewis Center, Ohio, Mfg: Watson Laboratories, Corona, CA NDC 62037-0696-90

Reason for Recall

Labeling: Label Mix Up; packages labeled as Thiamine actually contain Diltiazem Capsules

Details

Units Affected
89/120 mg tablets
Distribution
Product was shipped to the following states: CO, MA, OH, TX & WY.
Location
Lewis Center, OH

Frequently Asked Questions

What product was recalled?
Taztia XT (Diltiazem HCl) Capsules, 120 mg, Rx, Packaged and labeled as Thiamine. Re-Packaged By: Shamrock Medical Solutions, Lewis Center, Ohio, Mfg: Watson Laboratories, Corona, CA NDC 62037-0696-90. Recalled by Shamrock Medical Solutions Group LLC. Units affected: 89/120 mg tablets.
Why was this product recalled?
Labeling: Label Mix Up; packages labeled as Thiamine actually contain Diltiazem Capsules
Which agency issued this recall?
This recall was issued by the FDA Drug on July 30, 2014. Severity: Critical. Recall number: D-1446-2014.